| Literature DB >> 29931802 |
Shuli He1,2,3, Hongwang Zhang2, Yihao Liu1,4, Fan Sun2, Xiang Yu1, Xueyan Li1, Li Zhang1, Lichen Wang1, Keya Mao4, Gangshi Wang4, Yunjuan Lin4, Zhenchuan Han4, Renat Sabirianov5, Hao Zeng2.
Abstract
Maximized specific loss power and intrinsic loss power approaching theoretical limits for alternating-current (AC) magnetic-field heating of nanoparticles are reported. This is achieved by engineering the effective magnetic anisotropy barrier of nanoparticles via alloying of hard and soft ferrites. 22 nm Co0.03 Mn0.28 Fe2.7 O4 /SiO2 nanoparticles reach a specific loss power value of 3417 W g-1metal at a field of 33 kA m-1 and 380 kHz. Biocompatible Zn0.3 Fe2.7 O4 /SiO2 nanoparticles achieve specific loss power of 500 W g-1metal and intrinsic loss power of 26.8 nHm2 kg-1 at field parameters of 7 kA m-1 and 380 kHz, below the clinical safety limit. Magnetic bone cement achieves heating adequate for bone tumor hyperthermia, incorporating an ultralow dosage of just 1 wt% of nanoparticles. In cellular hyperthermia experiments, these nanoparticles demonstrate high cell death rate at low field parameters. Zn0.3 Fe2.7 O4 /SiO2 nanoparticles show cell viabilities above 97% at concentrations up to 500 µg mL-1 within 48 h, suggesting toxicity lower than that of magnetite.Entities:
Keywords: intrinsic loss power; magnetic anisotropy; magnetic hyperthermia; magnetic nanoparticles; specific loss power
Year: 2018 PMID: 29931802 DOI: 10.1002/smll.201800135
Source DB: PubMed Journal: Small ISSN: 1613-6810 Impact factor: 13.281